InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by James Gamgort. Director active across 1 company, notably IRLAB Therapeutics AB. Cumulatively, 4 disclosures have been published. Activity tracked since 7 July 2026. The latest transaction was filed on 8 July 2026 (Purchase). Regulator: FIN-FSA. The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
James Gamgort is a declarant linked to IRLAB Therapeutics AB, where he is Styrelseledamot. The record shows 4 filings in total, and across the 4 sampled recent filings between 2026-07-08 and 2026-07-09, the transactions are purchases for EUR 62940, with EUR 0 of sales.